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The addition of arachidonic acid to a suspension of digitonin-permeabilized human neutrophils was found 
to induce, in a dose-dependent manner (ED% about 15 PM), the release of calcium from internal stores. 
Arachidic acid was without effect, while linoleic acid and linolenic acid were (on a concentration basis) at 
least S-times less active than arachidonic acid. The activity of arachidonic acid appears to be due to the 
fatty acid itself and not to one of its metabolites. The pool of calcium mobilized by arachidonic acid includes 
that sensitive to inositol 1,4,5_trisphosphate. These results demonstrate a significant intracellular role for 
arachidonic acid at the level of the internal mobilization of calcium in human neutrophils. 
Arachidonic acid; Neutrophil; Inositol 1,4,5_trisphosphate; Ca*+ mobilization; Unsaturated fatty acid; Fura- 
1. INTRODUCTION 
Neutrophil stimulation by chemotactic factors is 
accompanied by the activation of the phospho- 
lipases C and AZ. Inositol 1,4,5-trisphosphate (IP3) 
and diacylglycerol, the products of phospholipase 
C, are involved in the liberation of calcium from 
the endoplasmic reticulum and the activation of 
protein kinase C, respectively [ 11. Arachidonic 
acid, the principal fatty acid liberated by phospho- 
lipase AZ, possesses biological activities of its own 
and is the parent molecule for the prostaglandins, 
prostacyclins and leukotrienes [2]. 
The roles of IP3 and of arachidonic acid and/or 
its metabolites are generally thought of as being 
distinct. However, several lines of evidence in- 
dicate that the lipid mediators play internal roles in 
neutrophil activation. For example, arachidonic 
acid and lipoxin A have been shown to activate 
directly purified preparations of protein kinase C 
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[3,4]. Furthermore, Wolf et al. [S] have demon- 
strated that arachidonic acid was capable of caus- 
ing a release of calcium in permeabilized 
preparations of pancreatic islets. 
The present studies were instigated in order to 
test for physiological evidence of intracellular ef- 
fects of arachidonic acid in human neutrophils. 
The results to be presented demonstrate that 
arachidonic acid mobilizes internal calcium in 
permeabilized neutrophils and HL-60 cells and 
that it does so at physiologically relevant concen- 
trations and in a relatively specific manner. 
2. MATERIALS AND METHODS 
Human peripheral blood neutrophils isolated 
following dextran sedimentation on Hypaque 
Ficoll gradients were used throughout these ex- 
periments. The cells were resuspended in Hanks’ 
balanced salt solution containing 10 mM Hepes, 
pH 7.0, in the absence of added calcium or 
magnesium. 
Calcium releask was monitored with the fluores- 
cent indicator fura-2. [6]. Briefly, neutrophils were 
resuspended in a high potassium buffer. containing 
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110 mM KCl, 10 mM NaCl, 2 mM KHzPOd, 
1 mM MgC12, 1 mM phenylmethylsulfonyl 
fluoride, and 25 mM Hepes, pH 7.0, at l-3 x lo7 
cells/ml. At the appropriate times, 1 mM ATP 
(Tris salt), 8 mM creatine phosphate, 16pg/ml 
creatine phosphokinase and 2 ,uM fura- were add- 
ed. The final cell concentration was lo7 cells/ml. 
The cells were transferred to the cuvette compart- 
ment of the spectrofluorometer (SLM In- 
struments, Urbana, IL) and the fluorescence 
monitored (excitation, 350 nm; emission, 510 nm) 
at 37°C. Cell permeabilization was initiated by the 
addition of digitonin (20pM, from a stock in 
ethanol at 10 mM maintained at 37°C during the 
course of the experiment). 
The promyelocytic leukemia cells HL-60 were 
maintained in culture as in [7]. 
Fura- was purchased from Molecular Probes 
(Eugene, OR). Tissue culture supplies were ob- 
tained from Gibco. All the other chemicals came 
from Sigma (St Louis, MO). 
3. RESULTS AND DISCUSSION 
The addition of digitonin to neutrophil suspen- 
sions causes a rapid and ATP-dependent (not 
shown) drop in fluorescence of fura- which cor- 
responds to a drop in the ambient levels of calcium 
due to accumulation of the cation by cell or- 
ganelles. The permeabilized cells did not respond 
to addition of the chemotactic peptide fMet-Leu- 
Phe. Furthermore, IP3 did not increase the fluores- 
Fig.1. Effect of arachidonic acid on the fura- fluores- 
cence of a suspension of permeabilized neutrophils. 
Arachidonic acid (20 PM) was added successively at the 
arrows to a suspension of neutrophils permeabilized as 
described in section 2. Representative of four such ex- 
periments. 
cence of fura- in non-permeabilized cells (not 
shown). The addition of arachidonic acid (20 PM) 
to digitonin-treated neutrophils causes an increase 
in the fluorescence of fura- (fig.1). A subsequent 
addition of the fatty acid is significantly less effec- 
tive. The fluorescence signal returns to the pre- 
stimulation level within the next lo-15 min (not 
shown). Arachidonic acid causes no increase in flu- 
orescence if added after the ionophore A23187, 
and the latter elicits a correspondingly smaller in- 
crease if added after arachidonic acid (not shown). 
The effect of arachidonic acid is dose-dependent 
and is detectable at, or below, 5 PM (fig.2). Max- 
imal release is observed at 50pM and the EDT,-, is 
approx. lo-20/1M. Direct effects of the fatty acid 
on the probe or generalized disruption of cellular 
membranes are ruled out by the observation that 
arachidonic acid did not cause any increase in the 
fluorescence of extracellular fura- when added to 
intact, non-permeabilized cells (not shown). 
The ability of arachidonic acid to induce a re- 
lease of calcium in the permeabilized neutrophils 
was unaffected by the inclusion in the incubation 
medium of the mitochondrial inhibitor antimycin 
A (1 PM) (not shown). These results indicate that 
the previously observed mobilization of calcium by 
arachidonic acid [8] may be due, at least in part, to 
a direct effect of the fatty acid on a non- 
mitochondrial calcium store. 
The pool of calcium mobilized by arachidonic 
acid includes that which is sensitive to IPr. The ad- 
dition of IP3 after that of a maximal dose of 
Fig.2. Dose dependence of the effect of arachidonic acid 
on the fluorescence of fura- of a suspension of per- 
meabilized neutrophils. Arachidonic acid was added at 
the arrow at the following concentrations: (1) 10 PM, (2) 
5 PM. Representative of three other determinations. 
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Fig.3. Sequential additions of IP3 and arachidonic acid 
to suspensions of permeabilized neutrophils in the 
presence of fura-2. (A) IP3 (5 PM) was added at the first 
arrow; arachidonic acid (5 PM) at the second arrow. (B) 
Arachidonic acid (5 PM) was added at the first arrow; 
IP3 (5 CM) at the second arrow. The two tracings are 
taken from sequential runs in the same experiments. Re- 
presentative of three determinations. 
Fig.4. Effect of various fatty acids on the fura- fluores- 
cence of a suspension of permeabilized neutrophils. The 
additions were made at the arrow: (1) arachidonic acid 
(lOpM), (2) linoleic acid (lOpM), (3) linolenic acid 
(10 pM), and (4) arachidic acid (10 pM). Representative 
of three other determinations. 
arachidonic acid is essentially without effect. On 
the other hand, arachidonic acid induces the re- 
lease of significant amounts of calcium even when 
added after IP3 (fig.3). These data indicate that 
arachidonic acid has access to a larger pool of cal- 
cium than does IP3, and conversely, that the pool 
of calcium affected by IP3 represents a subset of 
that sensitive to the fatty acid. It has been shown 
that IP3 releases only a fraction of the endoplasmic 
reticulum-associated calcium [9]. It should be 
pointed out that one cannot rule out at present he 
possibility that arachidonic acid inhibits directly 
the effects of IP3, possibly in a manner reminiscent 
of the previously described antagonism of the 
functional responsiveness of the neutrophils [lo]. 
The fatty acid specificity of the effect just 
described was ascertained by examining the ability 
of arachidic acid (the saturated counterpart of 
arachidonic acid), and of linoleic and linolenic acid 
(two long-chain cis unsaturated fatty acids) to in- 
duce the release of calcium in the permeabilized 
neutrophil preparation. The results of these studies 
are summarized in fig.4. Arachidic acid at concen- 
trations up to 50 PM was found not to cause any 
significant release of calcium. Linoleic and 
linolenic acid, on the other hand, did increase the 
fluorescence of fura- although these two fatty 
acids required at least 5-times higher concentra- 
tions than arachidonic acid to induce effects of a 
similar magnitude. Thus arachidonic acid displays 
a significant, though not absolute, specificity 
among the fatty acids as far as its ability to 
mobilize internal calcium is concerned. These 
results approximate those previously published 
concerning the effects of cis unsaturated fatty acid 
on the physical organization of the lipid domains 
of biological membranes [l 11, and on the func- 
tional responsiveness of the neutrophils [ 121. They 
suggest that the inhibition of the functional 
responsiveness of the neutrophils by the fatty acids 
may be the result of the dissipation of the func- 
tionally relevant internal calcium pool. 
Several ines of evidence indicate that the release 
of calcium induced by arachidonic acid is due to 
the fatty acid itself and not to one of its 
metabolites. Firstly, the permeabilization is likely 
to result in a dramatic dilution of the metabolizing 
enzymes (lipoxygenase and cyclooxygenase) and 
their necessary cofactors [ 131. Secondly, un- 
stimulated human neutrophils metabolize exo- 
genous arachidonic acid only very poorly. Thirdly, 
linoleic and linolenic acid elicit a release of cal- 
cium. Fourthly, IP3 and arachidonic acid exhibit 
similar activities in the HL-60 promyelocytic 
leukemia cells (not shown) which are known to be 
deficient in arachidonic acid-metabolizing enzymes 
[ 14,151. Finally, the lipoxygenase inhibitor nordi- 
hydroguaiaretic acid [16] failed to decrease the 
magnitude of the fura- response to arachidonic 
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acid (not shown). 131 
In summary, the results presented above demon- 
strate that arachidonic acid is an effective agent for 
the mobilization of internal calcium in the neutro- 
phils and the HL-60 cells. This effect is demonstra- 
ble at concentrations of the fatty acid that are 
comparable to those of IPs and the former releases 
significantly larger amounts of calcium than the 
latter mediator. By doing so, these studies tie to- 
gether and establish a new level of interrelationship 
between two previously relatively independent bio- 
chemical pathways called upon during neutrophil 
activation, namely the phospholipases C and AZ. 
The determination of the relative contributions of 
the products of these two pathways to the increase 
in calcium that accompanies the physiological 
stimulation of the neutrophils, and of the possible 
effects of the lipoxygenase-derived metabolites of 
arachidonic acid in this response, ‘remain to be 
determined. 
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